|
Volumn 46, Issue 4, 2005, Pages 329-334
|
The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 125 ANTIGEN;
PACLITAXEL;
PLATINUM DERIVATIVE;
TOPOTECAN;
ARTICLE;
BLOOD;
CHEMISTRY;
CYSTADENOCARCINOMA;
DRUG RESISTANCE;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
OVARY TUMOR;
PATHOLOGY;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
CA-125 ANTIGEN;
CYSTADENOCARCINOMA, MUCINOUS;
CYSTADENOCARCINOMA, PAPILLARY;
CYSTADENOCARCINOMA, SEROUS;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
NEOPLASM RECURRENCE, LOCAL;
OVARIAN NEOPLASMS;
PACLITAXEL;
PLATINUM COMPOUNDS;
TOPOTECAN;
TREATMENT OUTCOME;
|
EID: 33746427225
PISSN: 12200522
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|